Tender Details
Tender Title / Description
| Tender Title | EMPANELMENT OF DRUG TESTING LABORATORIES |
|---|---|
| Tender Description | isoflurane, 100% isoflurane, 100% inj. ketamine hcl, 57.7 mg of ketamine hcl equivalent to 50 mg of ketamine inj. propofol (1%), 10mg / ml sevoflurane, 99.97% sevoflurane, 99.97% inj. etomidate, 20 mg/ 10ml inj. bupivacaine, 5mg/ml inj. bupivacaine (heavy), bupivacaine 5mg/ml + dextrose 80mg / ml inj. levobupivacaine, 0.5%, 20mg/4ml lidocaine hydrochloride gel 2%, 2% w/v inj. lignocaine hcl, lignocaine hcl 21.3mg + nacl 6mg inj. lignocaine hcl andadrenaline bitartrate, lignocaine hcl - 21.3 mg / ml + adrenaline 0.005 mg / ml inj. lignocaine hcl(anti-arrhythmic), 2% w/v (without preservative) lignocaine spray topical , 4% w/v ropivacaine, 0.75% w/v inj. dexmedetomidine, 200mcg/2ml inj. glycopyrrolate, 0.2 mg/ml tab. glycopyrrolate(aluminium foil/ blister pack), 1mg/tab. inj. midazolam, 1 mg/ml inj. cisatracurium, 2mg/ml inj. ephedrine hcl, 30 mg/ml inj. neostigmine methylsulphate, 0.5 mg/ml inj. neostigmine methylsulphate + glycopyrrolate, neostigmine methylsulphate 2.5 mg + glycopyrr |
| Comments | isoflurane, 100% isoflurane, 100% inj. ketamine hcl, 57.7 mg of ketamine hcl equivalent to 50 mg of ketamine inj. propofol (1%), 10mg / ml sevoflurane, 99.97% sevoflurane, 99.97% inj. etomidate, 20 mg/ 10ml inj. bupivacaine, 5mg/ml inj. bupivacaine (heavy), bupivacaine 5mg/ml + dextrose 80mg / ml inj. levobupivacaine, 0.5%, 20mg/4ml lidocaine hydrochloride gel 2%, 2% w/v inj. lignocaine hcl, lignocaine hcl 21.3mg + nacl 6mg inj. lignocaine hcl andadrenaline bitartrate, lignocaine hcl - 21.3 mg / ml + adrenaline 0.005 mg / ml inj. lignocaine hcl(anti-arrhythmic), 2% w/v (without preservative) lignocaine spray topical , 4% w/v ropivacaine, 0.75% w/v inj. dexmedetomidine, 200mcg/2ml inj. glycopyrrolate, 0.2 mg/ml tab. glycopyrrolate(aluminium foil/ blister pack), 1mg/tab. inj. midazolam, 1 mg/ml inj. cisatracurium, 2mg/ml inj. ephedrine hcl, 30 mg/ml inj. neostigmine methylsulphate, 0.5 mg/ml inj. neostigmine methylsulphate + glycopyrrolate, neostigmine methylsulphate 2.5 mg + glycopyrr |
Important Dates
| Published Date | |
|---|---|
| Due Date | 23 Sep 2024 00:00:00 |
Estimate and EMD
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |